Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170018/S025

LIFEPAK CR2 Defibrillator

Physio-Control, Inc. · Decision date Jul 30, 2026

FDA DECISIONP170018/S025

What did the FDA decide?

FDA records P170018/S025 as a supplement to PMA P170018, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 30, 2026.

FDA approval order statement

implementation of an automated service testing process
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jul 30, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P170018/S025
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
OK30
Decision date
Jul 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P170018/S024 · Related supplement

    LIFEPACK CR2 Automated External Defibrillator (AED)

  2. P170018/S023 · Related supplement

    LIFEPAK CR2 Automated External Defibrillator

  3. P170018/S025 received

    Application receipt date recorded by FDA.

  4. P170018/S025 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P170018. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170018

Product / regulatory recordCompanyPathwayDecision dateSource
Physio-Control, Inc.PMA supplementSep 29, 2025FDA
Physio-Control, Inc.PMA supplementNov 6, 2025FDA

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Physio-Control, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11811 Willows Rd. NE, Redmond, WA, 98052

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records